Contact | Print version | PDF version | Send article | RSS feed

Enigma Diagnostics Announces Patent Licence With Applied Biosystems

27 Oct 2008 - Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems.
 
The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence Applied Biosystems has granted to the method claims of the '907 patent.
 
This complements Enigma's existing licence under certain patents owned by Applied Biosystems for real-time PCR thermal cyclers.